Insulin-Like Growth Factor Binding Protein-6 Promotes the Differentiation of Placental Mesenchymal Stem Cells into Skeletal Muscle Independent of Insulin-Like Growth Factor Receptor-1 and Insulin Receptor

Abstract

As mesenchymal stem cells (MSCs) are being investigated for regenerative therapies to be used in the clinic, delineating the roles of the IGF system in MSC growth and differentiation, in vitro, is vital in developing these cellular therapies to treat degenerative diseases. Muscle differentiation is a multistep process, starting with commitment to the muscle lineage and ending with the formation of multinucleated fibers. Insulin-like growth factor binding protein-6 (IGFBP-6), relative to other IGFBPs, has high affinity for IGF-2. However, the role of IGFBP-6 in muscle development has not been clearly defined. Our previous studies showed that in vitro extracellular IGFBP-6 increased myogenesis in early stages and could enhance the muscle differentiation process in the absence of IGF-2. In this study, we identified the signal transduction mechanisms of IGFBP-6 on muscle differentiation by placental mesenchymal stem cells (PMSCs). We showed that muscle differentiation required activation of both AKT and MAPK pathways. Interestingly, we demonstrated that IGFBP-6 could compensate for IGF-2 loss and help enhance the muscle differentiation process by triggering predominantly the MAPK pathway independent of activating either IGF-1R or the insulin receptor (IR). These findings indicate the complex interactions between IGFBP-6 and IGFs in PMSC differentiation into the skeletal muscle and that the IGF signaling axis, specifically involving IGFBP-6, is important in muscle differentiation. Moreover, although the major role of IGFBP-6 is IGF-2 inhibition, it is not necessarily the case that IGFBP-6 is the main modulator of IGF-2.

The Crosstalk between GPR81/IGFBP6 Promotes Breast Cancer Progression by Modulating Lactate Metabolism and Oxidative Stress

“…In the tumor microenvironment, increased lactate levels significantly activate GPR81, mediating the activation of cell survival signaling [ 25 ]. Among the most interesting biological processes reshaping cell metabolism, those that recap developmental processes through IGFBP6 involvement hold great potential to understand tumor-related biological processes, such as cell proliferation, wound healing, senescence, and changes in metabolism [ 26 ].…”

Insulin growth factor‑1 promotes the proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells through the Wnt/β‑catenin pathway

“…Studies have also confirmed that the development of IGF-1 knockout in mice is related to a decrease in the number of osteoblasts and a decrease in bone formation ability ( 9 , 10 ). Moreover, under pathological conditions, IGF-1 has been revealed to promote the mineralization of mesenchymal stem cells, thereby promoting fracture healing ( 11 ). However, the molecular mechanism by which IGF-1 promotes the proliferation and differentiation of BMSCs remains unclear.…”

MiR-22-3p Inhibits Proliferation and Promotes Differentiation of Skeletal Muscle Cells by Targeting IGFBP3 in Hu Sheep

“…Studies showed that IGFBP1 activates ERK1/2 pathway to promote the proliferation of smooth muscle cells (SMCs) by regulating IGF1 [ 34 ]. IGFBP6 inhibits the expression of IGF2 and activates the MAPK pathway to promote muscle differentiation, and the activation of this pathway does not require IGF-1R or insulin receptor (IR) to participate [ 35 ]. These findings reveal that the IGFBPs are involved in the growth and development of muscles.…”